AEP PLANTATIONS PLC financials
AEP PLANTATIONS PLC
Country: GB Reporting currency: USD Latest annual report: 2025-12-31
LEI:
2138009ROZICGP42QP19 ISIN: GB0000365774 Financial statements
(USD, as reported — unscaled; 107 line items across 2 annual periods)
| Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | $465.2M | $372.3M |
| Cost of sales | $340.0M | $286.6M |
| Gross profit | $123.8M | $88.6M |
| Other income | $1.3M | $1.5M |
| Administrative expenses | $14.2M | $9.4M |
| Operating profit (EBIT) | $111.6M | $81.7M |
| Finance costs | $44.0K | $65.0K |
| Profit before tax | $119.3M | $88.1M |
| Income tax expense | $33.0M | $20.5M |
| Profit for the year | $86.3M | $67.6M |
| — attributable to owners | $90.9M | $67.5M |
| — attributable to NCI | -$4.6M | $98.0K |
| Total comprehensive income | $72.5M | $44.8M |
| Per share | ||
| Basic EPS | $2.31 | $1.71 |
| Diluted EPS | $2.31 | $1.71 |
| Free cash flow / share | $2.25 | $1.14 |
| Cash flow statement | ||
| Cash generated from operations | $130.3M | $98.3M |
| Net cash from operating activities | $113.8M | $73.9M |
| Income taxes paid | $13.9M | $22.4M |
| Net cash from investing activities | -$13.2M | -$30.2M |
| Purchase of PP&E (capex) | $29.9M | $29.0M |
| Purchase of intangibles | $262.0K | $0 |
| Net cash from financing activities | -$46.3M | -$7.4M |
| Dividends paid | $34.6M | $5.9M |
| Net change in cash | $54.2M | $36.4M |
| Balance sheet | ||
| Non-current assets | $291.6M | $297.5M |
| Property, plant & equipment | $272.5M | $271.2M |
| Current assets | $344.3M | $303.1M |
| Inventories | $27.7M | $18.8M |
| Trade & other receivables | $9.0M | $7.1M |
| Cash & equivalents | $231.8M | $181.9M |
| Total equity | $584.9M | $558.5M |
| — attributable to owners | $580.7M | $551.0M |
| Non-controlling interests | $4.2M | $7.4M |
| Non-current liabilities | $11.4M | $13.8M |
| Lease liabilities (non-current) | $338.0K | $453.0K |
| Current liabilities | $39.6M | $28.4M |
| Lease liabilities (current) | $202.0K | $307.0K |
| Trade & other payables | $28.4M | $21.4M |
| Deferred tax liabilities | $3.1M | $2.2M |
| Derived metrics | ||
| Free cash flow | $83.9M | $44.9M |
| Operating margin | 24.0% | 22.0% |
| Net margin | 18.6% | 18.2% |
| Return on equity | 14.8% | 12.1% |
| Cash conversion ratio | 1.32× | 1.09× |
| Capex coverage | 3.80× | 2.55× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -$9.7M | -$2.9M |
| Adjustments For Decrease Increase In Trade and Other Receivables | -$1.5M | $5.6M |
| Adjustments For Depreciation Expense | $19.0M | $19.0M |
| Adjustments For Fair Value Gains Losses | $107.0K | -$1.1M |
| Adjustments For Finance Costs | $44.0K | $65.0K |
| Adjustments For Finance Income Cost | $8.0M | $5.4M |
| Adjustments For Gain Loss On Disposals Property Plant and Equipment | $95.0K | $380.0K |
| Adjustments For Gains Losses On Change In Fair Value Less Costs To Sell Biological Assets | -$1.4M | $2.9M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | -$710.0K | $133.0K |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | $2.2M | $2.8M |
| Adjustments For Increase Decrease In Trade and Other Payables | $7.5M | -$5.1M |
| Adjustments For Provisions | -$85.0K | -$9.0K |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -$23.0K | $31.0K |
| Capital Redemption Reserve | $1.1M | $1.1M |
| Cash | $231.8M | $181.9M |
| Cash Flows From Used In Operations Before Changes In Working Capital | $134.1M | $100.7M |
| Comprehensive Income Attributable To Noncontrolling Interests | -$3.2M | $194.0K |
| Comprehensive Income Attributable To Owners of Parent | $75.7M | $44.6M |
| Current Assets Liabilities | $304.7M | $274.7M |
| Current Biological Assets | $6.4M | $8.1M |
| Current Dividend Payables | $65.0K | $46.0K |
| Current Financial Assets At Fair Value Through Profit Or Loss | $22.0M | $24.0M |
| Current Investments | $500.0K | $1.3M |
| Current Payables On Social Security and Taxes Other Than Income Tax | $814.0K | $1.2M |
| Current Receivables From Taxes Other Than Income Tax | $41.9M | $43.7M |
| Current Tax Assets | $5.0M | $18.3M |
| Current Tax Liabilities | $10.2M | $5.5M |
| Deferred Tax Assets | $974.0K | $1.9M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | $34.6M | $5.9M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners | $16.8M | $20.1M |
| Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share | $0.44 | $0.51 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -$4.3M | -$7.5M |
| Finance Income | $8.0M | $5.4M |
| Gains Losses On Exchange Differences On Translation Net of Tax | -$15.7M | -$23.2M |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | -$176.0K | $1.1M |
| Gains Losses On Fair Value Adjustment Biological Assets | -$1.4M | $2.9M |
| Gains Losses On Financial Assets At Fair Value Through Profit Or Loss | -$107.0K | $1.1M |
| Impairment Loss Impairment Gain and Reversal of Impairment Loss Determined In Accordance With IFRS9 | -$710.0K | $133.0K |
| Increase Decrease Through Transactions With Owners | — | -$400.0K |
| Intangible Assets Other Than Goodwill | $262.0K | $0 |
| Interest Received Classified As Investing Activities | $8.0M | $5.4M |
| Investments In Associates | $1.0K | $0 |
| Issued Capital | $15.5M | $15.5M |
| Net Assets Liabilities | $584.9M | $558.5M |
| Noncurrent Financial Assets At Fair Value Through Profit Or Loss | $45.0K | $5.1M |
| Noncurrent Receivables | $17.8M | $19.4M |
| Noncurrent Recognised Liabilities Defined Benefit Plan | $8.0M | $11.1M |
| Other Comprehensive Income | -$13.8M | -$22.8M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | $1.9M | $378.0K |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -$15.7M | -$23.2M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | $1.9M | $378.0K |
| Payments To Acquire Or Redeem Entitys Shares | $11.4M | $640.0K |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | $325.0K | $872.0K |
| Proceeds From Sales Or Maturity of Financial Instruments Classified As Investing Activities | $36.0M | $28.1M |
| Purchase of Financial Instruments Classified As Investing Activities | $29.1M | $46.0M |
| Purchase of Interests In Associates | $1.0K | $0 |
| Purchase of Treasury Shares | $11.4M | $640.0K |
| Reserve of Exchange Differences On Translation | -$381.5M | -$364.4M |
| Retained Earnings | $935.5M | $877.4M |
| Share Premium | $23.9M | $23.9M |
| Treasury Shares | $13.8M | $2.5M |
Methodology
Every line item above is a fact tagged in AEP PLANTATIONS PLC's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (USD), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.